A Study of E3810 for Japanese Subjects With Functional Dyspepsia(SAMURAI Study:Suppression of Acid Milieu with Rabeprazole Improving Functional Dyspepsia)

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221232

Enrollment

320

Registered

2010-09-03

Start date

2010-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

investigational material(s) Generic name etc : E3810 INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material :

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects diagnosed as Functional Dyspepsia according to Rome III criteria.

Exclusion criteria

Exclusion criteria: -Subjects with neuropsychiatric disorder. -Subjects diagnosed as IBS, IBD and serious constipation

Design outcomes

Primary

Measure	Time frame
Resolution rate of dispeptic symptom at last visit in treatment period	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026